|
WO2007123939A2
|
|
Novel arylamino n-heteraryls as mek inhibitors
|
|
WO2007057444A1
|
|
Insl3/rlf polypeptides and uses thereof
|
|
WO2006120160A1
|
|
Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases
|
|
WO2006067170A1
|
|
G-csf polypeptides and uses thereof
|
|
WO2006067141A1
|
|
Cladribine regimen for treating multiple sclerosis
|
|
WO2006068901A2
|
|
Method and system for identifying gene-trait linkages
|
|
TW200633718A
|
|
Treatment of hepatitis c in the asian population
|
|
CA2581048A1
|
|
Use of pregnancy specific glycoprotein for maturation of oocytes
|
|
CA2579166A1
|
|
Use of il-17f for the treatment and/or prevention of neurologic diseases
|
|
UA88314C2
|
|
Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
|
|
CA2576765A1
|
|
Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
|
|
EP1760092A1
|
|
System for screening cells for high expression of a protein of interest
|
|
CA2572326A1
|
|
Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination
|
|
BRPI0513878A
|
|
n-hydroxyamide derivatives and their use
|
|
CA2565801A1
|
|
Use of il-17 in the treatment of fertility-related disorders
|
|
EP1756304A2
|
|
Rnai-based target identification and validation
|
|
KR20070008675A
|
|
1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
|
|
WO2005090971A1
|
|
Anti-lipid rafts antibodies
|
|
JP2005232177A
|
|
hGH CONTAINING PHARMACEUTICAL COMPOSITION
|
|
CA2554979A1
|
|
Method for fast substructure searching in non-enumerated chemical libraries
|
